|
|
post embryonic development
|
GO:0009791 |
2 |
0.534
|
|
|
|
sensory perception of pain
|
GO:0019233 |
4 |
0.470
|
|
|
|
cellular response to uv
|
GO:0034644 |
32 |
0.324
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.243
|
|
|
|
hormone catabolic process
|
GO:0042447 |
4 |
0.219
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.161
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.138
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.132
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.110
|
|
|
|
dna replication
|
GO:0006260 |
116 |
0.110
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.106
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.102
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.100
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.099
|
|
|
|
dna dependent dna replication
|
GO:0006261 |
44 |
0.099
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.097
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.088
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.086
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.084
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.084
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.081
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.079
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
4 |
0.076
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.073
|
|
|
|
hormone metabolic process
|
GO:0042445 |
61 |
0.071
|
|
|
|
response to uv
|
GO:0009411 |
73 |
0.070
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.068
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.066
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.065
|
|
|
|
endocrine process
|
GO:0050886 |
25 |
0.065
|
|
|
|
positive regulation of meiotic cell cycle
|
GO:0051446 |
2 |
0.065
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.064
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.064
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.062
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.061
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.059
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.058
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.058
|
|
|
|
oocyte maturation
|
GO:0001556 |
1 |
0.057
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.056
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
12 |
0.056
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.056
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.054
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.053
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.053
|
|
|
|
receptor metabolic process
|
GO:0043112 |
81 |
0.052
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.051
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.050
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.049
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.048
|
|
|
|
cellular response to light stimulus
|
GO:0071482 |
34 |
0.048
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.047
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.045
|
|
|
|
cellular hormone metabolic process
|
GO:0034754 |
41 |
0.045
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.044
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.044
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.042
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.040
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.040
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.040
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.040
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.040
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.040
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.039
|
|
|
|
regulation of microtubule polymerization or depolymerization
|
GO:0031110 |
27 |
0.039
|
|
|
|
system process
|
GO:0003008 |
349 |
0.038
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.038
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.038
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.037
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.037
|
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.037
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.037
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.037
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
12 |
0.036
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.036
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.036
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.036
|
Human |
|
|
endocytosis
|
GO:0006897 |
159 |
0.035
|
|
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.035
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.035
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.035
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.034
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.034
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.033
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.032
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.032
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.032
|
|
|
|
mononuclear cell proliferation
|
GO:0032943 |
71 |
0.031
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.031
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
4 |
0.031
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.031
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.031
|
|
|
|
growth
|
GO:0040007 |
202 |
0.030
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.030
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.030
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.030
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.030
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.029
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.029
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
92 |
0.029
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.029
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
82 |
0.028
|
|
|
|
cell aging
|
GO:0007569 |
52 |
0.028
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.028
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
65 |
0.028
|
|
|
|
peptide metabolic process
|
GO:0006518 |
51 |
0.028
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.028
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.028
|
|
|
|
calcitonin catabolic process
|
GO:0010816 |
1 |
0.027
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.027
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.027
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.027
|
|
|
|
regulation of dna replication
|
GO:0006275 |
68 |
0.026
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.026
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
84 |
0.026
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.026
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.026
|
|
|
|
head development
|
GO:0060322 |
108 |
0.025
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.025
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.025
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.025
|
|
|
|
t cell activation
|
GO:0042110 |
99 |
0.025
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.025
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
34 |
0.025
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.024
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.024
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.024
|
|
|
|
neuropeptide catabolic process
|
GO:0010813 |
2 |
0.023
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
119 |
0.023
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.023
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.023
|
|
|
|
meiosis i
|
GO:0007127 |
4 |
0.023
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.023
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.022
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
70 |
0.022
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.022
|
|
|
|
substance p catabolic process
|
GO:0010814 |
1 |
0.022
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.022
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.022
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.022
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.021
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.021
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.021
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.021
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.021
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.021
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
67 |
0.021
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.021
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.021
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.021
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.021
|
|
|
|
reproduction
|
GO:0000003 |
63 |
0.021
|
|
|
|
aging
|
GO:0007568 |
66 |
0.021
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.020
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.020
|
|
|
|
spindle organization
|
GO:0007051 |
53 |
0.020
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.020
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.020
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.020
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.020
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.020
|
|
|
|
lipid localization
|
GO:0010876 |
106 |
0.020
|
|
|
|
ncrna processing
|
GO:0034470 |
83 |
0.020
|
|
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.020
|
|
|
|
kidney development
|
GO:0001822 |
53 |
0.019
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
74 |
0.019
|
|
|
|
mitotic spindle elongation
|
GO:0000022 |
4 |
0.019
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.019
|
Human |
|
|
mitochondrial membrane organization
|
GO:0007006 |
40 |
0.019
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.019
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.019
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.019
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.018
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.018
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.018
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.018
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
4 |
0.018
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.018
|
|
|
|
cerebellum development
|
GO:0021549 |
2 |
0.018
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.018
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.018
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
84 |
0.018
|
|
|
|
lipid catabolic process
|
GO:0016042 |
84 |
0.018
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.018
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.018
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.018
|
|
|
|
protein folding
|
GO:0006457 |
38 |
0.018
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.018
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
69 |
0.018
|
|
|
|
phosphorylation of rna polymerase ii c terminal domain
|
GO:0070816 |
3 |
0.017
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.017
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.017
|
|
|
|
multi organism reproductive process
|
GO:0044703 |
54 |
0.017
|
|
|
|
cell projection assembly
|
GO:0030031 |
126 |
0.017
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.017
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.017
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.017
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.017
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.017
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.017
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.017
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.016
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.016
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.016
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.016
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.016
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
107 |
0.016
|
|
|
|
dicarboxylic acid metabolic process
|
GO:0043648 |
29 |
0.016
|
|
|
|
positive regulation of dna replication
|
GO:0045740 |
35 |
0.016
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.016
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.016
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
49 |
0.016
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.016
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.015
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.015
|
|
|
|
response to uv b
|
GO:0010224 |
10 |
0.015
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.015
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.015
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
81 |
0.015
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.015
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
71 |
0.015
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.015
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.015
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.015
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.015
|
|
|
|
tissue homeostasis
|
GO:0001894 |
63 |
0.015
|
|
|
|
dna recombination
|
GO:0006310 |
77 |
0.015
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.015
|
|
|
|
nuclear division
|
GO:0000280 |
128 |
0.015
|
|
|
|
positive regulation of leukocyte activation
|
GO:0002696 |
80 |
0.015
|
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
26 |
0.015
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.015
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.014
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.014
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
1 |
0.014
|
|
|
|
t cell homeostasis
|
GO:0043029 |
3 |
0.014
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
59 |
0.014
|
|
|
|
peptidyl tyrosine dephosphorylation
|
GO:0035335 |
36 |
0.014
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.014
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.014
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.014
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.014
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.014
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.014
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.014
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.014
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.014
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.013
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.013
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
99 |
0.013
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.013
|
|
|
|
associative learning
|
GO:0008306 |
1 |
0.013
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.013
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.013
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.013
|
|
|
|
dna conformation change
|
GO:0071103 |
113 |
0.013
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.013
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
74 |
0.013
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.013
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.013
|
|
|
|
jak stat cascade
|
GO:0007259 |
46 |
0.013
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.013
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.013
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.013
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.013
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.013
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.013
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.013
|
|
|
|
response to peptide
|
GO:1901652 |
65 |
0.013
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.012
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.012
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.012
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.012
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.012
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.012
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.012
|
|
|
|
erythrocyte development
|
GO:0048821 |
3 |
0.012
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.012
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.012
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.012
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.012
|
|
|
|
ncrna metabolic process
|
GO:0034660 |
108 |
0.012
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.012
|
|
|
|
double strand break repair via homologous recombination
|
GO:0000724 |
50 |
0.012
|
|
|
|
bradykinin catabolic process
|
GO:0010815 |
4 |
0.012
|
|
|
|
ribonucleoprotein complex biogenesis
|
GO:0022613 |
116 |
0.012
|
|
|
|
sleep
|
GO:0030431 |
2 |
0.012
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.012
|
|
|
|
organelle localization
|
GO:0051640 |
84 |
0.012
|
|
|
|
regulation of lipid catabolic process
|
GO:0050994 |
23 |
0.012
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.012
|
|
|
|
dna strand elongation involved in dna replication
|
GO:0006271 |
3 |
0.012
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.011
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.011
|
|
|
|
cellular amino acid catabolic process
|
GO:0009063 |
31 |
0.011
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
71 |
0.011
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.011
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.011
|
|
|
|
cellular amino acid biosynthetic process
|
GO:0008652 |
30 |
0.011
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.011
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.011
|
|
|
|
translation
|
GO:0006412 |
132 |
0.011
|
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.011
|
|
|
|
histone methylation
|
GO:0016571 |
60 |
0.011
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.011
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.011
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.011
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.011
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.011
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.011
|
|
|
|
neuron death
|
GO:0070997 |
65 |
0.011
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
50 |
0.011
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.011
|
|
|
|
activation of immune response
|
GO:0002253 |
114 |
0.011
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.011
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
77 |
0.011
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
28 |
0.011
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.011
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
56 |
0.011
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.010
|
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.010
|
|
|
|
negative regulation of t cell apoptotic process
|
GO:0070233 |
4 |
0.010
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
55 |
0.010
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.010
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.010
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.010
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
19 |
0.010
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.010
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
31 |
0.010
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.010
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.010
|
|